openPR Logo
Press release

Digital Simulations to Drive the Oncolytic Virus Immunotherapy Market

02-21-2022 01:41 PM CET | Health & Medicine

Press release from: Persistence Market Research

Digital Simulations to Drive the Oncolytic Virus Immunotherapy

The Oncolytic Virus Immunotherapy Market is all set to go great guns in the forecast period. Big data makes way for real-time data visualization, thereby identifying the high-risk populations. Healthcare organizations are into sharing more data. This creation and collection of bigger datasets are likely to increase precision and help organizations in spotting trends. These trends are expected to keep the entire healthcare vertical on the toes.

The new study report by Persistence Market Research (PMR) reveals that the oncolytic virus immunotherapy market value is all set to reach US$ ~67 Mn, by 2019-end. As per the PMR's report, the oncolytic virus immunotherapy market is estimated to grow at a CAGR of ~12% over the period of assessment, 2019-2029.

Increasing adoption of adjuvant therapy in developed economies has been fueling the demand for new treatments such as oncolytic virus immunotherapy. For instance, the launch of first FDA approved oncolytic virus, IMLYGIC™ (talimogene laherparepvec) by the leading pharmaceutical manufacturer Amgen has offered oncologists and patients a wider and more targeted treatment approach for overcoming cancer. Amgen's IMLYGIC™ remains the only FDA approved oncolytic virus immunotherapy drug that is prescribed for melanoma cancer.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/15262

Favorable reimbursement for oncolytic virus immunotherapy is poised to offer new growth opportunities for the market players. Additionally, Affordable Care Act in the U.S. is paving the way for successfully increasing insurance coverage for cancer treatment, and the result is likely to lead to increased demand for oncological therapies. Such factor along with several favorable policies for cancer treatment is anticipated to contribute immensely towards the growth of the oncolytic virus immunotherapy industry during the forecast period.

Company Profiles:

BioVex, Inc. (Amgen, Inc.)
Cold Genesys, Inc.
DNAtrix Therapeutics
Genelux Corporation
Lokon Pharma AB
Oncolytics Biotech, Inc.
ORYX GmbH & Co. KG
PsiOxus Therapeutics
SillaJen, Inc.
Sorrento Therapeutics, Inc.
Takara Bio
Targovax ASA
Transgene sa
Turnstone Biologics
VCN Biosciences
Viralytics Ltd. (Merck & Co., Inc.)
Vyriad
Shanghai Sunway Biotech

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/15262

Growing Prevalence of Metastatic Cancer Bringing in Massive Competition in the Oncolytic Virus Immunotherapy Landscape

According to PMR, growing prevalence of metastatic cancer and rising demand for adjuvant therapy drugs and cancer relapses during cancer treatment have created opportunities for key market players to come up with oncolytic virus immunotherapy products at competitive rates by combining new viruses. Apart from the top global market players such as BioVex, Inc. (Amgen, Inc.) and Shanghai Sunway Biotech Co. Ltd. (China), there are several other players in the regional oncolytic virus immunotherapy market that are constantly focusing on discovering new drug candidates in oncolytic virus immunotherapy.

Most of the drugs in the pipeline are in various stages of clinical trials awaiting market approvals. For example, oncolytic viruses from Transgene/Sillajen, Oncolytic Biotech and other players are in the late phase III stage of clinical trials, and are expected to enter the oncolytic virus immunotherapy market in the coming years.

According to the PMR's report, the adoption of oncolytic virus immunotherapy in hospitals will continue to account for relatively high market share, while stakeholders are targeted towards capitalizing on specialty clinics. A significant rise in demand for oncolytic virus immunotherapy drugs in developed countries will further work to the advantage of the market players.

A remarkable shift has been observed in the new drug development and product launch in cancer treatment drugs as the blockbuster drug model is dead. Key players are now adopting new strategies to develop adjuvant therapies and supportive therapies that can help irradiate cancer at the maximum level, such as oncolytic virus immunotherapy combined with chemotherapy. Such developmental trends are likely to remain instrumental to the growth of the oncolytic virus immunotherapy market.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/15262

Increasing Immunotherapy Research Will Offer New Growth Prospects

According to the PMR study, increasing importance of R&D in oncology medicines and immunotherapies for cancers such as colorectal, lung, multiple myeloma, prostate, and melanoma is expected to create immense growth opportunities for the oncolytic virus immunotherapy market.

Besides this, collaborations among the key players in the pharmaceutical industry, funding programs and reimbursement policies to meet the unmet diagnostic and treatment needs of the patients suffering from life-threatening diseases such as cancer are also expected to fuel the growth of the oncolytic virus immunotherapy market.

Growing interest of biopharmaceutical industries in the development of biologics for various cancers, will further expand the pipeline for the treatment of cancer. Various major players are concentrating on the research for the available treatment and development of specific oncolytic virus for cancer, which will boost the market for oncolytic virus immunotherapy during the forecast period. Further, growing acceptance of oncolytic drugs among patient pool is also high due to treatment effectiveness of the medication. Hence, companies operating in oncolytic virus immunotherapy are expected to mostly derive profit from the development of adoptive immune viruses.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/oncolytic-virus-immunotherapy-market.asp

The funding for cancer research and investments in cancer therapy and oncolytic virus immunotherapy have increased, which has increased the number of personnel employed and projects undertaken. The major sources of research and development spending include governments, private funding, venture capitalists or commercial organizations.

Business analysts from PMR also demonstrate groundbreaking views on the development of the oncolytic virus immunotherapy market along with insights on key business approaches and policies by competitors in the oncolytic virus immunotherapy business.

Related Reports:

Induced Pluripotent Stem Cells Market - https://www.persistencemarketresearch.com/market-research/induced-pluripotent-stem-cells-market.asp

Bile Duct Cancer Treatment Market - https://www.persistencemarketresearch.com/market-research/bile-duct-cancer-treatment-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Simulations to Drive the Oncolytic Virus Immunotherapy Market here

News-ID: 2558797 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for Bio

Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the